// App-Quantinova.ai

Mo1214 : Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Pursuit-SC Maintenance Study Extension

Researchers

Presenter

  • Walter Reinisch

Principal Investigators

  • William Sandborn

  • Paul J. Rutgeerts

  • Brian G. Feagan

  • Colleen W. Marano

  • Richard Strauss

  • Jewel Johanns

  • Hongyan Zhang

  • Lakshmi Padgett

  • Jean-Frederic Colombel

  • Judith Collins

Medical Centers

  • University Hospital Gasthuisberg, Leuven, Belgium

  • University of California, San Diego, La Jolla, CA

  • Universitatsklinik fur Innere Medizin IV, Austria

  • Hopital Claude Huriez, Lille, France

  • The Alfred Hospital, Melbourne, Australia

  • Oregon Health and Science University, Portland, OR

  • Robarts Research Institute, University of Western Ontario, London, Ontario, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

  • Austria

  • Australia

  • United States

  • France

  • Belgium

Companies

  • Janssen Global Servi

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ulcerative colitis

  • Colorectal Cancer

  • Sepsis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • golimumab

Outcome

  • N/A

Study Design

  • randomized

  • cross over

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved